314 related articles for article (PubMed ID: 38607068)
1. The Emerging Role of LPA as an Oncometabolite.
Karalis T; Poulogiannis G
Cells; 2024 Apr; 13(7):. PubMed ID: 38607068
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
Willier S; Butt E; Grunewald TG
Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid signalling in development.
Sheng X; Yung YC; Chen A; Chun J
Development; 2015 Apr; 142(8):1390-5. PubMed ID: 25852197
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptors in cancer pathobiology.
Tsujiuchi T; Araki M; Hirane M; Dong Y; Fukushima N
Histol Histopathol; 2014 Mar; 29(3):313-21. PubMed ID: 24194373
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
9. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
10. [Lysophosphatidic acid and malignant neoplasms].
Jesionowska A; Cecerska-Heryć E; Marczuk N; Safranow K; Dołęgowska B
Postepy Biochem; 2015; 61(4):381-7. PubMed ID: 27048092
[TBL] [Abstract][Full Text] [Related]
11. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
Xu J; Lai YJ; Lin WC; Lin FT
J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic Acid Signaling in Diabetic Nephropathy.
Lee JH; Kim D; Oh YS; Jun HS
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212704
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
[TBL] [Abstract][Full Text] [Related]
14. Diverse effects of LPA receptors on cell motile activities of cancer cells.
Tsujiuchi T; Hirane M; Dong Y; Fukushima N
J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
[TBL] [Abstract][Full Text] [Related]
15. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.
Van Leeuwen FN; Olivo C; Grivell S; Giepmans BN; Collard JG; Moolenaar WH
J Biol Chem; 2003 Jan; 278(1):400-6. PubMed ID: 12393875
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells.
Kim EK; Park JM; Lim S; Choi JW; Kim HS; Seok H; Seo JK; Oh K; Lee DS; Kim KT; Ryu SH; Suh PG
J Biol Chem; 2011 Jul; 286(27):24036-45. PubMed ID: 21602274
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
Valdés-Rives SA; González-Arenas A
Mediators Inflamm; 2017; 2017():9173090. PubMed ID: 29430083
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid as an autocrine and paracrine mediator.
Xie Y; Gibbs TC; Meier KE
Biochim Biophys Acta; 2002 May; 1582(1-3):270-81. PubMed ID: 12069838
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid in atherosclerotic diseases.
Schober A; Siess W
Br J Pharmacol; 2012 Oct; 167(3):465-82. PubMed ID: 22568609
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic Acid (LPA) Receptor 3-Mediated LPA Signal Transduction Pathways: A Possible Relationship with Early Development of Peri-Implantation Porcine Conceptus.
Jeong W; Seo H; Sung Y; Ka H; Song G; Kim J
Biol Reprod; 2016 May; 94(5):104. PubMed ID: 27030044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
